Initial assessment of outpatient visits to the cannabis abuse clinics

 

Initial assessment of outpatient visits to the cannabis abuse clinics

Tendances n° 50, OFDT, 4 p.
September 2006

Within the framework of the government's action plan against illicit drugs, tobacco and alcohol (2004-2008), a prevention programme against cannabis use has been up. In February 2005, this programme included an awareness- raising media campaign and the setting up of specific outpatient clinics targeting people who have, or think they may have, an addiction to cannabis. These "riskassessment clinics" have been closely associated with the existing addiction treatment system.
The aim of these "clinics for young users" has been to offer young people an assessment of their consumption and a diagnosis of harmful use; to offer personalised information and advice to "high risk" users, to provide shortterm care to young people reporting harmful use without social or psychiatric complications; to accompany and provide counselling advice to young people if their situation warrants it; to offer support to parents having difficulties in coping with their children's consumption; to offer, if necessary, joint support for parents and children.
The objective of the present survey is to provide an insight into the population attending the clinics, by comparison with cannabis users in the general population. What specific treatment do these outpatient clinics offer to people with cannabis-related problems? How are they effective as a means to access care structures?

Author :
Ivana Obradovic

Download the PDF file (648 Ko)

 

 

 

 

 

Drugs in Europe


2021 EMCDDA European Drug Report

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2021

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.